Beginning on 1 October 2023, the Food and Drug Administration will refuse to accept premarket submissions that do not include information from the cybersecurity amendments of the Food, Drug and Cosmetic Act.
The FDA will allow sponsors a grace period from the enactment of the amendments—today, 29 March—until 1 October, where it will not issue RTAs for premarket submissions that do not